Translating knowledge

IOCBTech is a technology transfer office and subsidiary company of IOCB (the Institute of Organic Chemistry and Biochemistry CAS). The company matches results of basic research done at the IOCB with needs of commercial partners to ultimately bring new ideas in medicinal chemistry, material sciences, and other fields of chemistry to human use.

Oxytocin

OXYTOCINTM

1958
Remestyp

TERLIPRESINTM

1965
Dermazulen

DERMAZULENTM

1969
Minirin

DESMOPRESINTM

1970
Usal

USALTM

1975
Adiuretin

ADIURETINTM

1975
Duvira gel

DUVIRA GELTM

1980
Duratocin

DURATOCINTM

1985
Vistide

VISTIDETM

1996

VIREADTM

2001

HEPSERATM

2002

TRUVADATM

2004

ATRIPLATM

2006

COMPLERATM

2011

STRIBILDTM

2012

GENVOYATM

2015

VEMLIDYTM

2016

SYMTUZATM

2018

Projects & Opportunities

Here you can explore our projects which are available for co-development or licensings.

About IOCB Tech

The IOCB Tech team supports management and decision-making processes in Target Research Groups of IOCB e.g. by due diligence analyses, market potential studies, and project feasibility evaluation. Moreover, the company is responsible for networking and industry partner search or negotiations of contracts and agreements in the field of intellectual property.

An integral part of IOCB Tech’s duties is the organization and development of spin-off companies on IOCB’s technology platform.

News

08/08
2022

Summary of IOCB Tech activities in 2021

08/08/2022
About us IOCB Tech (TECH) is a leading tech transfer company focused on the translation of scientific and research findings to practice. The primary concentration is on medicinal chemistry, materials science and diagnostics, but also other fields. Its main objective is to connect science and business so that the results…
04/06
2022

Young Czech Scientists Head to Israel Thanks to New Scientific Internship Project

04/06/2022
Czech-Israeli Innovation Internships are a new programme of study internships that will enable young scientists to experience science in Israel with a focus on commercialisation and technology transfer. In the pilot phase, the program was supported by IOCB Tech, the Czech-Israeli Joint Chamber of Commerce, the 1st Medical Faculty of…
01/26
2022

Czech science to receive hundreds of millions of koruna from IOCB Tech

01/26/2022
OCB Tech, a subsidiary of the Institute of Organic Chemistry and Biochemistry (IOCB) of the Czech Academy of Sciences, will distribute approximately CZK 250 million to support Czech science, research and innovation next year. These funds will be used to create spin-off companies involved in the pharmaceutical, diagnostics and medical…
12/23
2020

PF 2021

12/23/2020
IOCB Tech team wishes you peaceful holidays and a good entry into the new year 2021.

Where to meet us?

BIO US Digital 2021

When: 14/06/2021 – 18/06/2021
Where: Digital

Description:

The IOCB Tech team will be at Bio US Digital 2021. Look at our partnering platform with the company profile and assets. Looking forward to virtual meetings in June.

BioEurope Spring (Digital) 2021

When: 22/03/2021 – 25/03/2021
Where: Digital

Description:

The IOCB Tech team will be at Bio-Europe Spring (Digital) 2021. Look at our partnering platform with the company profile and assets. Looking forward to virtual meetings in March.  …

BioSpot 2020

When: 05/03/2020 – 05/03/2020
Where: National Library of Technology, Prague

Description:

BioSpot is organized annually to bring Central European life-science researchers face-to-face with industry representatives. And will be held the 5th time this year in Prague.

Bio-Europe Spring – Paris 2020

When: 22/03/2020 – 25/03/2020
Where: Paris

Description:

The IOCBTech team will be at Bio-Europe Spring in Paris. Come and meet us in person or follow us on Twitter @IOCBTech…

BioVaria 2020

When: 27/04/2020 – 28/04/2020
Where: Munich, Germany (map)

Description:

IOCBTech will be participating together with i&iPrague as PowerPartner at this year’s BioVaria. An event that targets technology scouts, business developers and investors highlighting commercially attractive licensing opportunities and promising startups from across Europe. BioVaria brings together innovators from universities, research institutes and startups with Europe’s leading tech transfer…

XV. EILAT Novel Antiepileptic Drugs Conference

When: 07/06/2020 – 10/06/2020
Where: Meliá Castilla Hotel & Convention Center in Madrid, Spain

Description:

Our team member Jana Kenney will be on the 15th EILAT Conference on Novel Antiepileptics in Madrid, Spain.